Identification and cloning of the Mycobacterium avium folA gene, required for dihydrofolate reductase activity

FEMS Microbiology Letters

Volumn 156, Issue 1, 1997, Pages 69-78

  Zywno Van Ginkel, Sabrina ^a   Dooley, Thomas P ^a   Suling, William J ^a   Barrow, William W ^a  

^a SOUTHERN RESEARCH INSTITUTE   (United States)

Author keywords

Antimycobacterial; Cloning; Dihydrofolate reductase; FolA; Mycobacteria; Mycobacterium avium

Indexed keywords

BACTERIAL ENZYME; DIHYDROFOLATE REDUCTASE; FOLIC ACID;

AMINO ACID SEQUENCE; ARTICLE; CONSENSUS SEQUENCE; CONTROLLED STUDY; DNA SEQUENCE; ESCHERICHIA COLI; GENETIC COMPLEMENTATION; MOLECULAR CLONING; MYCOBACTERIUM AVIUM; NONHUMAN; OPEN READING FRAME; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; BASE SEQUENCE; CLONING, MOLECULAR; CONSERVED SEQUENCE; DNA PRIMERS; DNA, BACTERIAL; ESCHERICHIA COLI; GENE EXPRESSION; GENES, BACTERIAL; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; MYCOBACTERIUM AVIUM COMPLEX; OPEN READING FRAMES; POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; TETRAHYDROFOLATE DEHYDROGENASE;

EID: 0031277801     PISSN: 03781097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1097(97)00402-3     Document Type: Article

References (28)

1. Bowden, K., Harris, N.V. and Watson, C.A. (1993) Structure-activity relationships of dihydrofolate reductase inhibitors. J. Chemother. 5, 377-388.
2. McCourt, M. and Cody, V. (1991) Conformational analysis of lipophilic antifolates: Crystal structure of 2-amino-4-oxo-6-adamantylpteridine and a comparison of its binding to bacterial and avian dihydrofolate reductase. J. Am. Chem. Soc. 113, 6634-6639.
3. Hartman, P.G. (1993) Molecular aspects and mechanism of action of dihydrofolate reductase inhibitors. J. Chemother. 5, 369-376.
4. Colwell, W.T., Brown, V.H., DeGraw, J.I. and Morrison, N.E. (1979) Inhibition of mycobacterial dihydrofolic reductase by 2,4-diamino-6-alkylpteridines and deazapteridines. In: Chemistry and Biology of Pteridines (Kisliuk, R.L. and Brown, G.M., Eds.), pp. 215-218. Elsevier North Holland, Amsterdam.
5. Czaplinski, K.-H., Hänsel, W., Wiese, M. and Seydel, J.K. (1995) New benzylpyrimidines: inhibition of DHFR from various species. QSAR, CoMFA and PC analysis. Eur. J. Med. Chem. 30, 779-787.
6. Meyer, S.C.C., Majumder, S.K. and Cynamon, M.H. (1995) In vitro activities of PS-15, a new dihydrofolate reductase inhibitor, and its cyclic metabolite against Mycobacterium avium complex. Antimicrob. Agents Chemother. 39, 1862-1863.
7. Ellner, J.J., Goldberger, M.J. and Parenti, D.M. (1991) Mycobacterium avium infection and AIDS: A therapeutic dilemma in rapid evolution. J. Infect. Dis. 163, 1326-1335.
8. Morris, S.L. and Rouse, D.A. (1996) The genetics of multiple drug resistance in Mycobacterium tuberculosis and the Mycobacterium avium complex. Res. Microbiol. 147, 68-73.
9. Rastogi, N., Fréhel, C., Ryter, A., Ohayon, H., Lesourd, M. and David, H.L. (1981) Multiple drug-resistance in Mycobacterium avium: is the cell wall architecture responsible for the exclusion of antimicrobial agents? Antimicrob. Agents Chemother. 20, 666-677.
10. Rastogi, N. and Barrow, W.W. (1994) Laboratory and clinical aspects of the Mycobacterium avium epidemic: Contributing factors associated with variability of drug susceptibility and immune responsiveness and the multifaceted nature of pathogenicity. 11th Forum in Microbiology. Res. Microbiol. 145, 167-261.
11. Chiu, J., Nussbaum, J., Bozzette, S., Tilles, J.G., Young, L.S., Leedom, J., Heseltine P.N. and McCutchan, J.A. (1990) Treatment of disseminated Mycobacterium avium complex infection in AIDS with amikacin, ethambutol, rifampin, and ciprofloxacin. Ann. Intern. Med. 113, 358-361.
12. Singer, S., Ferone, R., Walton, L. and Elwell, L. (1985) Isolation of a dihydrofolate reductase-deficient mutant of Escherichia coli. J. Bacteriol. 164, 470-472.
13. Sambrook, J., Fritsch, E.F. and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
14. Devereux, J., Haeberli, P. and Smithies, O. (1984) A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res. 12, 387-395.
15. Hillcoat, B.L., Dixon, P.F. and Blakley, R.L. (1967) Effect of substrate decomposition on the spectrophotometric assay of dihydrofolate reductase. Anal. Biochem. 21, 178-189.
16. Vasanthakumar, G., van Ginkel, S. and Parish, G. (1994) Isolation and sequencing of a cDNA encoding the Hypoxanthine-guanine phosphoribosyltransferase from Toxoplasma gondii. Gene 147, 153-154.
17. Anderson, S.G.E. and Sharp, P.M. (1996) Codon usage in the Mycobacterium tuberculosis complex. Microbiology 142, 915-925.
18. Clark-Curtiss, J.E. (1990). Genome structure of mycobacteria. In Molecular Biology of the Mycobacteria (McFadden, J., Ed.), pp. 77-96. Surrey University Press, London.
19. Bergh, S. and Cole, S.T. (1994) MycDB: an integrated mycobacterial data base. Mol. Microbiol. 12, 517-534.
20. Philipp, W.J., Poulet, S., Eiglmeier, K., Pascopella, L., Balasubramanian, V., Heym, B., Bergh, S., Bloom, B.R., Jacobs, J. and Cole, S.T. (1996) An integrated map of the genome of the tubercle bacillus, Mycobacterium tuberculosis H37Rv, and comparison with Mycobacterium leprae. Proc. Natl. Acad. Sci. USA. 93, 3132-3137.
21. Cohn, D.L. and C.R. Horsburgh, J. (1995) Treatment and prophylaxis of disseminated Mycobacterium avium complex infection in AIDS. In: Opportunistic Complications of HIV (Gordin, F.M., Ed.), pp. 6-12. Meniscus Health Care Communications, Philadelphia, PA.
22. Villarino, E. and O'Brien, R. (1996) The use of HIV protease inhibitors with rifampin. TB Notes (CDC) 3, 15-18.
23. Baccanari, D.P. and Kuyper, L.F. (1993) Basis of selectivity of antibacterial diaminopyrimidines. J. Chemother. 5, 393-399.
24. Piper, J.R., Johnson, C.A., Krauth, C.A., Carter, R.L., Hosmer, C.A., Queener, S.F., Borotz, S.E. and Pfefferkorn, E.R. (1996) Lipophilic antifolates as agents against opportunistic infections. 1. Agents superior to trimetrexate and piritrexim against Toxoplasma gondii and Pneumocystis carinii in in vitro evaluations. J. Med. Chem. 39, 1271-1280.
25. Bradley, M.P. and Crippen, G.M. (1993) Voronoi modeling: The binding of triazines and pyrimidines to L. casei dihydrofolate reductase. J. Med. Chem. 36, 3171-3177.
26. Roth, B. (1986) Design of dihydrofolate reductase inhibitors from X-ray crystal structures. FASEB J. 45, 2765-2772.
27. Al-Rubeai, M. and Dale, J.W. (1986) Purification and characterization of dihydrofolate reductase from Mycobacterium phlei. Biochem. J. 235, 301-303.
28. Sirawaraporn, W., Sirawaraporn, R., Chanpongsri, A., Jacobs, J. and Santi, D.V. (1991) Purification and characterization of dihydrofolate reductase from wild-type and trimethoprim-resistant Mycobacterium smegmatis. Exp. Parasitol. 72, 184-190.